Literature DB >> 31628197

Interplay between ubiquitylation and SUMOylation: Empowered by phase separation.

Jianping Jin1.   

Abstract

Ubiquitin and the ∼20 human ubiquitin-like proteins regulate numerous aspects of cell biology via interlinked mechanisms that have not been fully elucidated. Sha et al. now explore the interplay between ubiquitylation and SUMOylation, finding that inhibition of ubiquitylation enhances SUMOylation of hundreds of newly synthesized proteins and that the resultant pools are stored in phase-separated protein condensates called PML nuclear bodies. These unexpected outcomes identify a new role for SUMOylation and raise new questions about cell behavior under normal and stress conditions.
© 2019 Jin.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31628197      PMCID: PMC6802507          DOI: 10.1074/jbc.H119.011037

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Ubiquitin-like proteins.

Authors:  Annemarthe G van der Veen; Hidde L Ploegh
Journal:  Annu Rev Biochem       Date:  2012-03-09       Impact factor: 23.643

2.  SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation.

Authors:  J M Desterro; M S Rodriguez; R T Hay
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

3.  Comparative proteomic analysis identifies a role for SUMO in protein quality control.

Authors:  Michael H Tatham; Ivan Matic; Matthias Mann; Ronald T Hay
Journal:  Sci Signal       Date:  2011-06-21       Impact factor: 8.192

Review 4.  The Ubiquitin System, Autophagy, and Regulated Protein Degradation.

Authors:  Alexander Varshavsky
Journal:  Annu Rev Biochem       Date:  2017-06-20       Impact factor: 23.643

5.  PML, SUMO, and RNF4: guardians of nuclear protein quality.

Authors:  Anne Gärtner; Stefan Muller
Journal:  Mol Cell       Date:  2014-07-03       Impact factor: 17.970

Review 6.  Principles of Ubiquitin-Dependent Signaling.

Authors:  Eugene Oh; David Akopian; Michael Rape
Journal:  Annu Rev Cell Dev Biol       Date:  2018-08-15       Impact factor: 13.827

Review 7.  Regulation of NF-κB by ubiquitination.

Authors:  Jueqi Chen; Zhijian J Chen
Journal:  Curr Opin Immunol       Date:  2013-01-08       Impact factor: 7.486

Review 8.  Building and remodelling Cullin-RING E3 ubiquitin ligases.

Authors:  John R Lydeard; Brenda A Schulman; J Wade Harper
Journal:  EMBO Rep       Date:  2013-11-15       Impact factor: 8.807

9.  Converging Small Ubiquitin-like Modifier (SUMO) and Ubiquitin Signaling: Improved Methodology Identifies Co-modified Target Proteins.

Authors:  Sabine A G Cuijpers; Edwin Willemstein; Alfred C O Vertegaal
Journal:  Mol Cell Proteomics       Date:  2017-09-26       Impact factor: 5.911

10.  Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies.

Authors:  Zhe Sha; Tamara Blyszcz; Román González-Prieto; Alfred C O Vertegaal; Alfred L Goldberg
Journal:  J Biol Chem       Date:  2019-07-08       Impact factor: 5.157

  10 in total
  5 in total

1.  SUMOylation regulates the number and size of promyelocytic leukemia-nuclear bodies (PML-NBs) and arsenic perturbs SUMO dynamics on PML by insolubilizing PML in THP-1 cells.

Authors:  Seishiro Hirano; Osamu Udagawa
Journal:  Arch Toxicol       Date:  2022-01-10       Impact factor: 5.153

2.  RTL8 promotes nuclear localization of UBQLN2 to subnuclear compartments associated with protein quality control.

Authors:  Harihar Milaganur Mohan; Hanna Trzeciakiewicz; Amit Pithadia; Emily V Crowley; Regina Pacitto; Nathaniel Safren; Bryce Trotter; Chengxin Zhang; Xiaogen Zhou; Yang Zhang; Venkatesha Basrur; Henry L Paulson; Lisa M Sharkey
Journal:  Cell Mol Life Sci       Date:  2022-03-05       Impact factor: 9.207

Review 3.  LncRNAs: Architectural Scaffolds or More Potential Roles in Phase Separation.

Authors:  Jie Luo; Lei Qu; Feiran Gao; Jun Lin; Jian Liu; Aifu Lin
Journal:  Front Genet       Date:  2021-03-31       Impact factor: 4.599

Review 4.  Liquid-Liquid Phase Separation in Cancer Signaling, Metabolism and Anticancer Therapy.

Authors:  Sebastian Igelmann; Frédéric Lessard; Gerardo Ferbeyre
Journal:  Cancers (Basel)       Date:  2022-04-05       Impact factor: 6.639

5.  Effects of arsenic on the topology and solubility of promyelocytic leukemia (PML)-nuclear bodies.

Authors:  Seishiro Hirano; Osamu Udagawa
Journal:  PLoS One       Date:  2022-05-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.